Comparative Efficacy of Laser Systems and Fluoride in Managing Dentinal Hypersensitivity: RCT

NCT ID: NCT07141576

Last Updated: 2025-08-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

96 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-09-01

Study Completion Date

2026-09-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This randomized controlled clinical trial aims to compare the effectiveness of Erbium laser (2940 nm), Diode laser (650 nm), combination Diode laser with fluoride varnish, and fluoride varnish alone in treating dentinal hypersensitivity. The study will recruit 96 adults aged 18-45 years with tooth sensitivity scores ≥4 on a 0-10 Visual Analogue Scale, randomly allocating 24 participants to each of four treatment groups. The primary outcome is reduction in tooth sensitivity measured at baseline, 1 week, 4 weeks, and 6 months post-treatment, with patient satisfaction as a secondary outcome. Conducted at Cairo University's Faculty of Dentistry, this 6-month follow-up study addresses the limitation of current treatments that provide only temporary relief, seeking to establish evidence-based protocols for optimal long-term management of dentinal hypersensitivity by evaluating whether laser therapies alone or in combination with fluoride offer superior and more durable pain relief compared to standard fluoride treatment alone.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This randomized controlled clinical trial investigates the comparative efficacy of different laser systems and fluoride-based treatments for managing dentinal hypersensitivity, a prevalent clinical condition characterized by sharp, transient pain from exposed dentin in response to thermal, evaporative, tactile, or chemical stimuli. The study will recruit 96 participants aged 18-45 years with dentinal hypersensitivity scores ≥4 on a Visual Analogue Scale (VAS), randomly allocating them into four equal groups (n=24 each): Group 1 receiving Erbium:YAG laser treatment (2940 nm, 80mJ, 2Hz) which works through thermal tubule occlusion; Group 2 receiving Diode laser photobiomodulation therapy (650 nm, 100mW, 2J total dose) targeting neural modulation; Group 3 receiving combination therapy of Diode laser with 5% sodium fluoride varnish to exploit synergistic mechanisms; and Group 4 receiving fluoride varnish alone as the control comparator. The primary outcome measures dentinal hypersensitivity reduction using VAS scores (0-10 scale) assessed through standardized evaporative stimulus tests at baseline, 1 week, 4 weeks, and 6 months post-treatment, while secondary outcomes include patient satisfaction and treatment tolerability. Conducted at the Conservative Dentistry Department, Faculty of Dentistry, Cairo University, with blinded outcome assessors and standardized protocols, this superiority trial addresses the clinical need for evidence-based, long-term effective treatments for dentinal hypersensitivity by comparing individual laser modalities against combination therapy and established fluoride treatments, potentially establishing optimal therapeutic protocols that provide both immediate relief and sustained tubule occlusion or neural modulation for improved patient quality of life.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dentin Sensitivity, Dentine Hypersensitivity, Tooth Sensitivity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

This randomized controlled trial uses a single-blind, parallel-group design to compare four treatments for dentinal hypersensitivity in 96 participants. Using computer-generated randomization and sealed envelope allocation, participants are equally divided into four groups receiving Erbium laser, Diode laser, combination Diode laser with fluoride, or fluoride alone. The study employs blinded outcome assessors, sham procedures to minimize bias, and follows participants for 6 months with Visual Analogue Scale measurements at baseline, 1 week, 4 weeks, and 6 months to assess treatment effectiveness.
Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors
This randomized controlled trial uses a single-blind, parallel-group design to compare four treatments for dentinal hypersensitivity in 96 participants. Using computer-generated randomization and sealed envelope allocation, participants are equally divided into four groups receiving Erbium laser, Diode laser, combination Diode laser with fluoride, or fluoride alone. The study employs single-blind masking where outcome assessors and statisticians remain blinded to treatment assignments, while sham procedures (simulated laser/fluoride applications) minimize bias where complete blinding is impossible. Participants are followed for 6 months with Visual Analogue Scale measurements at baseline, 1 week, 4 weeks, and 6 months to assess treatment effectiveness using standardized protocols and pre-calibrated examiners.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Erbium Laser

Erbium:YAG laser (2940 nm) treatment alone using thermal ablation to seal dentinal tubules and reduce hypersensitivity.

Group Type EXPERIMENTAL

Diode laser (650 nm): Visible red light energy

Intervention Type OTHER

Non-ionizing radiation or more accurately as optical energy devices, not ionizing radiation.

Fluoride varnish

Intervention Type DRUG

Biological Intervention

Diode Laser

Diode laser (650 nm) photobiomodulation therapy alone targeting neural modulation to reduce pain transmission.

Group Type EXPERIMENTAL

Erbium laser (2940 nm): Infrared light energy

Intervention Type OTHER

The lasers emit light energy in the infrared and visible spectrum, which is fundamentally different from ionizing radiation (like X-rays or gamma rays) that can damage DNA. Dental lasers work through photobiomodulation and thermal effects, not through radiation exposure.

Fluoride varnish

Intervention Type DRUG

Biological Intervention

Combination Therapy

Diode laser (650 nm) followed immediately by fluoride varnish application combining neural modulation with tubule occlusion.

Group Type EXPERIMENTAL

Erbium laser (2940 nm): Infrared light energy

Intervention Type OTHER

The lasers emit light energy in the infrared and visible spectrum, which is fundamentally different from ionizing radiation (like X-rays or gamma rays) that can damage DNA. Dental lasers work through photobiomodulation and thermal effects, not through radiation exposure.

Diode laser (650 nm): Visible red light energy

Intervention Type OTHER

Non-ionizing radiation or more accurately as optical energy devices, not ionizing radiation.

Fluoride varnish

Intervention Type DRUG

Biological Intervention

Fluoride Control

5% sodium fluoride varnish alone serving as active control, promoting remineralization and tubule occlusion through standard treatment.

Group Type ACTIVE_COMPARATOR

Erbium laser (2940 nm): Infrared light energy

Intervention Type OTHER

The lasers emit light energy in the infrared and visible spectrum, which is fundamentally different from ionizing radiation (like X-rays or gamma rays) that can damage DNA. Dental lasers work through photobiomodulation and thermal effects, not through radiation exposure.

Diode laser (650 nm): Visible red light energy

Intervention Type OTHER

Non-ionizing radiation or more accurately as optical energy devices, not ionizing radiation.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Erbium laser (2940 nm): Infrared light energy

The lasers emit light energy in the infrared and visible spectrum, which is fundamentally different from ionizing radiation (like X-rays or gamma rays) that can damage DNA. Dental lasers work through photobiomodulation and thermal effects, not through radiation exposure.

Intervention Type OTHER

Diode laser (650 nm): Visible red light energy

Non-ionizing radiation or more accurately as optical energy devices, not ionizing radiation.

Intervention Type OTHER

Fluoride varnish

Biological Intervention

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adults aged 18-45 years
* Both sexes eligible
* Good general health status
* At least one tooth with cervical dentin hypersensitivity (CDH)
* Visual Analogue Scale (VAS) pain score ≥ 4 on evaporative stimulus test using dental syringe air jet
* Willing to participate and provide informed consent

Exclusion Criteria

* Active carious lesions or defective restorations requiring treatment
* Loss of dental tissue requiring restorative treatment
* Previous professional desensitizing treatment within 6 months prior to recruitment
* Use of desensitizing toothpastes within 3 months prior to study
* Current use of anti-inflammatory drugs or analgesics at time of recruitment
* Pregnant or breastfeeding women
* Inability to comply with study protocol or follow-up requirements
Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cairo University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ayman Mohamed Elamin Taha

Assistant Lecturer

Responsibility Role PRINCIPAL_INVESTIGATOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CairoU-Laser Hypersensitivity

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.